Identifying a new microRNA signature as a prognostic biomarker in colon cancer
Fig 2
Survival analysis in the training and validation cohorts.
In the training (a) and validation (b) cohorts, the patients were split into groups of high and low risk. Survival analysis was conducted by Kaplan‐Meier analysis and log-rank test.